Heartbeam Inc (BEAT)

$1.95 +0.23 (13.37%)
Market Cap 66.91M
Revenue (ttm) 0.00
Net Income (ttm) -19.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 215,200
Avg Vol 106,342
Day's Range N/A - N/A
Shares Out 34.31M
Stochastic %K 92%
Beta -0.64
Analysts Sell
Price Target $8.00

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in...

Industry: Health Information Services
Sector: Healthcare
Phone: (408) 899-4443
Address:
2118 Walsh Avenue, Suite 210, Santa Clara, United States
StockHounding
StockHounding Oct. 5 at 1:33 AM
$PAVS $3 This is a triple with pending q4 news stated in filings Well, we are here peeps $ARBK has been a heavy one, but now popular $SOPA rally $BEAT is going to do something huge
0 · Reply
firmbiz123
firmbiz123 Oct. 4 at 1:09 AM
$BEAT what’s the difference between FDA cleared and approval???
1 · Reply
Oil_Pal
Oil_Pal Oct. 3 at 9:36 PM
$BEAT
0 · Reply
firmbiz123
firmbiz123 Oct. 3 at 9:14 PM
$BEAT
0 · Reply
Pedja1980
Pedja1980 Oct. 3 at 9:03 PM
$BEAT BEATW I am playing warrant on that name
2 · Reply
Rolltide2020
Rolltide2020 Oct. 3 at 8:02 PM
$BEAT Hmmm, strong close. Think someone might know something?
0 · Reply
firmbiz123
firmbiz123 Oct. 3 at 7:34 PM
$BEAT This company is in a great spot to change the way heart monitoring has been and what it will do for the future. I have had heart problems myself ,knowing there could be a “at home “ Device to check my heart status is a game changer. HUGE potential here.
0 · Reply
Thomas144
Thomas144 Oct. 3 at 5:29 PM
$BEAT
0 · Reply
gapureau
gapureau Oct. 3 at 4:08 PM
$BEAT Started to post that due to Gov't shutdown there might be no FDA news till resolved. Since SEC has this on it's home page: https://www.sec.gov/ But then I saw this company this morning $ANRO with FDA news so I guess we could still see something at any time. https://finance.yahoo.com/news/alto-neuroscience-receives-fda-fast-113400725.html
1 · Reply
Jptrader3
Jptrader3 Oct. 3 at 3:27 PM
$BEAT Nice surprise
1 · Reply
Latest News on BEAT
HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Sep 8, 2025, 7:00 AM EDT - 26 days ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 28, 2025, 7:00 AM EDT - 5 weeks ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

HeartBeam, Inc. (BEAT) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 9:17 PM EDT - 7 weeks ago

HeartBeam, Inc. (BEAT) Q2 2025 Earnings Call Transcript

HeartBeam Reports Second Quarter 2025 Results

Aug 13, 2025, 4:01 PM EDT - 7 weeks ago

HeartBeam Reports Second Quarter 2025 Results

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 30, 2025, 7:00 AM EDT - 2 months ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jul 22, 2025, 7:00 AM EDT - 2 months ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

Jun 17, 2025, 7:00 AM EDT - 3 months ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:40 PM EDT - 5 months ago

HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript

HeartBeam Reports First Quarter 2025 Results

May 13, 2025, 4:01 PM EDT - 5 months ago

HeartBeam Reports First Quarter 2025 Results

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 6, 2025, 7:00 AM EDT - 5 months ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 5, 2025, 7:00 AM EDT - 5 months ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

May 1, 2025, 8:31 AM EDT - 5 months ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 29, 2025, 8:31 AM EDT - 5 months ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Apr 24, 2025, 8:31 AM EDT - 5 months ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 9:02 PM EDT - 7 months ago

HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 13, 2025, 4:01 PM EDT - 7 months ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Mar 6, 2025, 9:01 AM EST - 7 months ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 27, 2025, 8:31 AM EST - 7 months ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 25, 2025, 4:01 PM EST - 7 months ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 8 months ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Jan 29, 2025, 8:31 AM EST - 8 months ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 23, 2024, 8:31 AM EST - 10 months ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Dec 16, 2024, 8:31 AM EST - 10 months ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 19, 2024, 8:31 AM EST - 11 months ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:22 PM EST - 11 months ago

HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript

HeartBeam Reports Third Quarter 2024 Results

Nov 7, 2024, 4:05 PM EST - 11 months ago

HeartBeam Reports Third Quarter 2024 Results

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Oct 17, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Sep 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Sep 10, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 8:51 PM EDT - 1 year ago

HeartBeam, Inc. (BEAT) Q2 2024 Earnings Call Transcript

HeartBeam Reports Second Quarter 2024 Results

Aug 14, 2024, 4:05 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2024 Results

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

Aug 1, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

HeartBeam Added to Russell Microcap® Index

Jul 1, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Added to Russell Microcap® Index

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

Jun 25, 2024, 9:00 AM EDT - 1 year ago

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

May 20, 2024, 8:31 AM EDT - 1 year ago

HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

May 13, 2024, 8:31 AM EDT - 1 year ago

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript

May 12, 2024, 10:36 AM EDT - 1 year ago

HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript

HeartBeam Reports First Quarter 2024 Results

May 9, 2024, 4:05 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2024 Results

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

Apr 25, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

Apr 9, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:35 PM EDT - 1 year ago

HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20, 2024, 4:05 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG

Mar 14, 2024, 8:31 AM EDT - 1 year ago

First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo™ System for Synthesizing a 12-Lead ECG

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

Mar 7, 2024, 8:31 AM EST - 1 year ago

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

Mar 5, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

Dec 14, 2023, 8:31 AM EST - 1 year ago

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

HeartBeam, Inc. (BEAT) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 7:10 PM EST - 2 years ago

HeartBeam, Inc. (BEAT) Q3 2023 Earnings Call Transcript

HeartBeam Reports Third Quarter 2023 Financial Results

Nov 14, 2023, 4:01 PM EST - 2 years ago

HeartBeam Reports Third Quarter 2023 Financial Results

StockHounding
StockHounding Oct. 5 at 1:33 AM
$PAVS $3 This is a triple with pending q4 news stated in filings Well, we are here peeps $ARBK has been a heavy one, but now popular $SOPA rally $BEAT is going to do something huge
0 · Reply
firmbiz123
firmbiz123 Oct. 4 at 1:09 AM
$BEAT what’s the difference between FDA cleared and approval???
1 · Reply
Oil_Pal
Oil_Pal Oct. 3 at 9:36 PM
$BEAT
0 · Reply
firmbiz123
firmbiz123 Oct. 3 at 9:14 PM
$BEAT
0 · Reply
Pedja1980
Pedja1980 Oct. 3 at 9:03 PM
$BEAT BEATW I am playing warrant on that name
2 · Reply
Rolltide2020
Rolltide2020 Oct. 3 at 8:02 PM
$BEAT Hmmm, strong close. Think someone might know something?
0 · Reply
firmbiz123
firmbiz123 Oct. 3 at 7:34 PM
$BEAT This company is in a great spot to change the way heart monitoring has been and what it will do for the future. I have had heart problems myself ,knowing there could be a “at home “ Device to check my heart status is a game changer. HUGE potential here.
0 · Reply
Thomas144
Thomas144 Oct. 3 at 5:29 PM
$BEAT
0 · Reply
gapureau
gapureau Oct. 3 at 4:08 PM
$BEAT Started to post that due to Gov't shutdown there might be no FDA news till resolved. Since SEC has this on it's home page: https://www.sec.gov/ But then I saw this company this morning $ANRO with FDA news so I guess we could still see something at any time. https://finance.yahoo.com/news/alto-neuroscience-receives-fda-fast-113400725.html
1 · Reply
Jptrader3
Jptrader3 Oct. 3 at 3:27 PM
$BEAT Nice surprise
1 · Reply
firmbiz123
firmbiz123 Oct. 3 at 3:18 PM
$BEAT Up 11% off no news. Hmmmmmm
0 · Reply
firmbiz123
firmbiz123 Oct. 3 at 3:17 PM
$BEAT ODD volume today… Think we’re getting close to FDA
0 · Reply
Oil_Pal
Oil_Pal Oct. 1 at 8:06 PM
$BEAT vs FDA See FDA your not all knowing, you didn’t approve Heart Beam day one of the fourth quarter well we shut you down 🤣
1 · Reply
Jptrader3
Jptrader3 Oct. 1 at 2:21 PM
$BEAT
0 · Reply
firmbiz123
firmbiz123 Sep. 30 at 8:21 PM
$BEAT Hopefully FDA coming soon!!
0 · Reply
Rolltide2020
Rolltide2020 Sep. 29 at 10:20 PM
$BEAT Would be nice to get FDA clearance tomorrow am before government shutdown.
2 · Reply
firmbiz123
firmbiz123 Sep. 29 at 8:15 PM
$BEAT https://www.businesswire.com/news/home/20241216069324/en/
1 · Reply
firmbiz123
firmbiz123 Sep. 29 at 8:13 PM
$BEAT
0 · Reply
firmbiz123
firmbiz123 Sep. 29 at 8:11 PM
$BEAT https://www.businesswire.com/news/home/20250129808981/en/
0 · Reply
firmbiz123
firmbiz123 Sep. 29 at 8:06 PM
$BEAT I think we are in a great position right now. When/if FDA approval, we can see HUGE gains. This is a strong BUY in my opinion
1 · Reply
Rolltide2020
Rolltide2020 Sep. 26 at 7:47 PM
$BEAT Q4 starts next week. Let the clearing begin.
2 · Reply
NetworkNewsWire
NetworkNewsWire Sep. 26 at 7:26 PM
NetworkNewsBreaks – $BEAT ECG System Offers Real-Time Cardiac Insights https://nnw.fm/foYgM
0 · Reply